Beta
Back to PG.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

PG Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q3'26, Procter & Gamble's (PG) operating expenses totaled $5.94B USD, entirely attributed to SG&A expenses, as R&D expenses remained at no data across all periods. This latest figure reflects a slight quarterly decline from $6.01B USD in Q2'26. Over the period from Q4'23 to Q3'26, SG&A expenses exhibited a generally stable to modestly increasing trend, fluctuating between $5.52B USD and $6.30B USD, with notable peaks in Q4'24 ($6.30B USD) and Q2'26 ($6.01B USD) amid overall operational consistency. The absence of R&D data throughout suggests no reported expenditures in this category, resulting in a stacked bar chart dominated solely by SG&A, highlighting its role as the primary driver of operating costs with minimal volatility year-over-year.